Zhang Xunzhi, Kumar Ashwani, Gong Xin, Xing Chao, Mootha V Vinod
Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas.
Ophthalmol Sci. 2024 Aug 30;5(1):100611. doi: 10.1016/j.xops.2024.100611. eCollection 2025 Jan-Feb.
An intronic cytosine-thymine-guanine (CTG) triplet repeat expansion in the transcription factor 4 gene () gene (CTG18.1) confers significant risk for the development of Fuchs' endothelial corneal dystrophy (FECD). The objective of this study was to conduct an unbiased survey of the CTG18.1 repeat expansion allele frequencies in a multiethnic population-based cohort from the United States and in global populations.
Cross-sectional study.
Dallas Heart Study (DHS) cohort including 1599 African Americans (AAs), 1028 European Americans (EAs), and 458 Latinos; 2500 individuals from the 1000 Genomes Project (1KGP) sampled from 26 populations across 5 continents.
We genotyped the CTG18.1 short tandem repeat (STR) in DHS using targeted polymerase chain reaction amplification followed by fragment analysis. We also inferred the CTG18.1 repeat genotype based on short-read whole-genome sequencing in 1KGP using the computational tool ExpansionHunter.
The prevalence of an expanded CTG18.1 allele with 40 repeats was determined in United States and global populations.
The carrier rates of the expanded allele were 3.1%, 8.1%, and 3.3% in AAs, EAs, and Latinos, respectively, in the DHS, and 2.7%, 9.5%, 5.2%, 7.2%, and 5.2% in the African (AFR), European (EUR), East Asian, South Asian, and admixed American continental populations, respectively, in the 1KGP. The distributions of the CTG18.1 repeat in DHS and in 1KGP are similar. The median repeat length was ∼17 with the interquartile range between 12 and 23 in the DHS populations. The median repeat length was ∼19 in all the 1KGP populations with the interquartile range between 13 and 26. The highest prevalence of the expanded allele carriers ranging from 12.1% to 12.5% was observed in some EUR and admixed American subpopulations. The frequency of expanded alleles carriers was absent or low (0%-1.9%) in subpopulations of West Africa but was present at 6.2% in a Kenyan subpopulation in East Africa.
The repeat expansion is most prevalent in people of EUR ancestry and least in AFR ancestry, which is consistent with FECD prevalence. The expanded CTG18.1 allele is the most common disease-causing STR in humans with worldwide implications for corneal disease.
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
转录因子4基因()基因(CTG18.1)内含子中的胞嘧啶 - 胸腺嘧啶 - 鸟嘌呤(CTG)三联体重复序列扩增会显著增加发生富克斯角膜内皮营养不良(FECD)的风险。本研究的目的是对来自美国的多民族人群队列以及全球人群中的CTG18.1重复序列扩增等位基因频率进行无偏倚调查。
横断面研究。
达拉斯心脏研究(DHS)队列,包括1599名非裔美国人(AA)、1028名欧裔美国人(EA)和458名拉丁裔;来自千人基因组计划(1KGP)的2500名个体,这些个体从五大洲的26个群体中抽样。
我们使用靶向聚合酶链反应扩增,随后进行片段分析,对DHS中的CTG18.1短串联重复序列(STR)进行基因分型。我们还使用计算工具ExpansionHunter,基于1KGP中的短读长全基因组测序推断CTG18.1重复基因型。
在美国和全球人群中确定具有40次以上重复的CTG18.1扩增等位基因的患病率。
在DHS中,AA、EA和拉丁裔中扩增等位基因的携带率分别为3.1%、8.1%和3.3%;在1KGP中,非洲(AFR)、欧洲(EUR)、东亚、南亚和美洲混合大陆群体中扩增等位基因的携带率分别为2.7%、9.5%、5.2%、7.2%和5.2%。DHS和1KGP中CTG18.1重复序列的分布相似。DHS人群中重复序列长度的中位数约为17,四分位间距在12至23之间。1KGP所有群体中重复序列长度的中位数约为19,四分位间距在13至26之间。在一些EUR和美洲混合亚群体中观察到扩增等位基因携带者的患病率最高,在12.1%至12.5%之间。西非亚群体中扩增等位基因携带者的频率不存在或很低(0% - 1.9%),但在东非的一个肯尼亚亚群体中为6.2%。
该重复序列扩增在EUR血统人群中最为普遍,在AFR血统人群中最少,这与FECD的患病率一致。扩增的CTG18.1等位基因是人类中最常见的致病STR,对角膜疾病具有全球影响。
在本文末尾的脚注和披露中可能会找到专有或商业披露信息。